Author

Johann Gout

DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER
DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER

Johann Gout  et al.

THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER
THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER

Johann Gout  et al.

ATM-DEFICIENT TUMOR EPITHELIA RESHAPE PANCREATIC CANCER-ASSOCIATED FIBROBLASTS TO FOSTER CANCER AGGRESSIVENESS VIA A DRUGGABLE TGF Β SIGNALING AXIS
ATM-DEFICIENT TUMOR EPITHELIA RESHAPE PANCREATIC CANCER-ASSOCIATED FIBROBLASTS TO FOSTER CANCER AGGRESSIVENESS VIA A DRUGGABLE TGF Β SIGNALING AXIS

Johann Gout  et al.

TUMORAL STATUS OF ATM DETERMINES CANCER-ASSOCIATED FIBROBLAST CELL FATE IN PANCREATIC DUCTAL ADENOCARCINOMA
TUMORAL STATUS OF ATM DETERMINES CANCER-ASSOCIATED FIBROBLAST CELL FATE IN PANCREATIC DUCTAL ADENOCARCINOMA

Johann Gout  et al.

A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE
A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE

Johann Gout  et al.

Item 21 - 25 / 25
1
2